Showing results (1-10 of 299) with videos related to
Sort By:
Pageof 30
JMA Journal|November 5, 2020
Lipotoxicity, Nutrient-Sensing Signals, and Autophagy in Diabetic NephropathyShinji Kume, Hiroshi MaegawaJournal of Diabetes Investigation|February 9, 2017
Metabolic and hemodynamic effects of sodium-dependent glucose cotransporter 2 inhibitors on cardio-renal protection in the treatment of patients with type 2 diabetes mellitusAtsunori Kashiwagi, Hiroshi MaegawaNihon Rinsho. Japanese Journal of Clinical Medicine|February 11, 2009
[Obesity as risk for developing diabetes]Hiroshi Maegawa, Atsunori KashiwagiJournal of Diabetes Investigation|January 14, 2022
A new era of diabetic kidney disease treatment with sodium-glucose cotransporter-2 inhibitorsShinji Kume, Hiroshi MaegawaJournal of Diabetes Investigation|July 13, 2020
Role of O-linked N-acetylglucosamine in the homeostasis of metabolic organs, and its potential links with diabetes and its complicationsKatsutaro Morino, Hiroshi MaegawaNihon Rinsho. Japanese Journal of Clinical Medicine|December 16, 2015
[Infection complicated with diabetes mellitus]Ken-ichi Nemoto, Hiroshi MaegawaNihon Rinsho. Japanese Journal of Clinical Medicine|December 2, 2015
[Hypertension and diabetes mellitus]Shin-ichi Araki, Hiroshi MaegawaJournal of Diabetes Investigation|June 21, 2020
Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patientsAtsunori Kashiwagi, Shinchi Araki, Hiroshi MaegawaAntioxidants (Basel, Switzerland)|March 6, 2021
Roles of mTOR in Diabetic Kidney DiseaseMako Yasuda-Yamahara, Shinji Kume, Hiroshi MaegawaExpert Opinion on Pharmacotherapy|July 28, 2016
Baseline characteristics and interim (3-month) efficacy and safety data from STELLA-LONG TERM, a long-term post-marketing surveillance study of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practiceHiroshi Maegawa, Kazuyuki Tobe, Hiromi Tabuchi, et al.Pageof 30